Are you a life science innovator seeking funding in the next 12 months? Applications are open for PitchRounds at AdvanSE 2022.

Accelerator, Blog, Cardiology & Cardiothoracic, Conferences, Design & Development, Digital Health, Events, GCMI, GI, neurology, News, orthopedic, Physician Innovators, Preclinical CRO Excellence, Regenerative Medicine, spine, T3

Our colleagues at Southeast Life Sciences are now accepting applications for Pitchrounds at AdvanSE 2022.   They’re seeking the southeast’s most promising life science innovators across multiple life science categories including biopharma, medtech, diagnostic, digital health and agriculture biotechnology technologies.   Along with Southeast Life Sciences, we encourage those seeking early rounds of six figures…

A Safer Way to Conduct Pericardiocentesis – A Procedure Begging for a Technology to Reduce Mortality

Blog, Cardiology & Cardiothoracic, GCMI, How GCMI Supports Georgia Tech Innovators, Researchers, PIs and Students, News, Preclinical CRO Excellence, T3

Meet Georgia Tech BME Fall 2021 Capstone Team Five of Hearts   The Unmet Need Heart disease, Viral infections, autoimmune diseases, and cancer can all cause excess fluid to fill the pericardial sac. Physicians frequently perform “pericardiocentesis” by inserting a large 18-gauge needle through the patient’s chest and into the pericardial space to drain this…

What high value preclinical support looks like when re-expressing pacemaking cells for cardiac arrhythmia in pediatrics

Blog, Cardiology & Cardiothoracic, GCMI, How GCMI Supports Georgia Tech Innovators, Researchers, PIs and Students, News, Preclinical CRO Excellence, Regenerative Medicine, T3, Uncategorized

“Our confidence in data generated by our in vivo studies with T3 Labs cannot be greater.” – Dr. Hee Cheol Cho   The Preclinical Challenge Dr. Hee Cheol Cho and his team needed sufficient feasibility data from physiologically appropriate preclinical studies to pursue public funding opportunities to complete their translational research for a life changing…

Spotlight: Regenerating Pacemaking Cells for Treatment of Cardiac Arrhythmias with Dr. Hee Cheol Cho

Blog, Cardiology & Cardiothoracic, GCMI, News, Physician Innovators, Preclinical CRO Excellence, T3

Preclinical proficiency and Georgia ‘medtech’ ecosystem assets yield data needed for follow-on, translational funding   The Problem – When Nature Doesn’t Give Us the ‘Pacemaking’ Cells We Need at Birth   Sometimes nature does not provide enough of the human heart’s own, rare and precious, ‘pacemaking cells’. When this occurs, at any stage of life,…

Heading to ORS 2022? Meet with GCMI’s Director of Scientific Affairs Evan Goldberg onsite for end-to-end product development insights including preclinical

Blog, Conferences, GCMI, orthopedic, T3

If you’re attending ORS 2022 and have a new orthopedic technology in development, including preclinical work that may be on your product development horizon, you have a wonderful chance to connect with our Director of Scientific Affairs Evan Goldberg onsite.   GCMI and our preclinical arm T3 Labs has substantial experience in preclinical work for…

Faculty Researchers and Innovators: What you need to know about IRBs and the medtech innovation process – Insights & Recording

Blog, Cardiology & Cardiothoracic, Design & Development, Digital Health, GCMI, GI, How GCMI Supports Georgia Tech Innovators, Researchers, PIs and Students, neurology, News, orthopedic, Physician Innovators, Preclinical CRO Excellence, Regenerative Medicine, spine, T3, Webinar

New medical technologies or devices cannot enter stages of research or clinical trials in humans without certain authorizations required by regulatory agencies responsible for safety and efficacy. As far as those regulatory bodies are concerned, the path to clinical trials in humans is the same whether it’s research or commercial driven. Failing to walk that…

Georgia Tech researchers partner with GCMI to move their innovative IV Sensor closer to clinical trials

Blog, Cardiology & Cardiothoracic, Design & Development, GCMI, How GCMI Supports Georgia Tech Innovators, Researchers, PIs and Students, News, T3

In 2014, a Children’s Healthcare of Atlanta nurse, Lynn Pogue, approached an engineer, Leanne West from Georgia Tech, to discuss the burden of IV monitoring. This is when Sherry Farrugia, the current Chief Executive Officer of GCMI, stepped in to help assemble the team that would begin the investigation into a new device capable of…

Demand, Logistics, Technologies and Lifecycle Services: The State of Bioskills Training and Education

Bio-skills and medical device training, Blog, Cardiology & Cardiothoracic, GCMI, GI, neurology, News, orthopedic, Physician Innovators, Preclinical CRO Excellence, Regenerative Medicine, spine, T3

Since the first quarter of 2020 the demand for virtual bioskills training and education programs for medical technologies has skyrocketed . Teams leaned on virtual engagement technologies, dedicated lab staff, and proctors onsite, to deliver the training and education required to learn how to safely employ new technologies, products and techniques. At the importance of…

From Capstone through CREATE-X and on to the precipice of commercialization: Ethos Medical’s medtech journey for its novel spinal guidance system

Blog, GCMI, How GCMI Supports Georgia Tech Innovators, Researchers, PIs and Students, News, Preclinical CRO Excellence, spine, T3

In 2018, GCMI chronicled one Georgia Tech Capstone team’s effort to end complications from epidural misplacement.   Fast forward more than three years and the promising product dubbed Neuraline has evolved to become a new medtech startup: Ethos Medical. The Ethos team leveraged the supporting elements and mentors within the Georgia Tech CREATE-X program—with assistance…

The State of Preclinical Studies: A Q&A with GCMI’s Director of Scientific Affairs Evan Goldberg

Blog, Cardiology & Cardiothoracic, GCMI, GI, neurology, News, orthopedic, Physician Innovators, Preclinical CRO Excellence, Regenerative Medicine, spine, T3

Our lives, personal and professional, bear little resemblance to those we led at the beginning of 2020. Remarkably, in February 2021, U.S. FDA announced the agency “approved, cleared, or authorized a record high of 132 novel medical devices in 2020, surpassing the 40-year high mark we set in 2018 and capping off 10 years of…